ARCHIVES

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

This article is from The Cancer Letter archive.

Vol. 14 No. 43 | November 4, 1988

Download PDF Visit The Full Archive

Related Articles

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

May 24, 1996

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Shaky Start For FY11 Appropriations Cycle As Congress Feels Pressure to Cut Spending

June 4, 2010

Cancer Program Critics Called “Irresponsible,” Demagogues”

March 21, 1975

Cancer Atlast Offers New Research Leads

July 17, 1987

NCCS Networker Volume 1 Issue 2, Summer 1987

June 13, 1987